Rx for Biotech

Nov 11 2024 60 ep. 26 mins 10
Rx for Biotech Podcast artwork

The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn more about Advanced Therapies, visit our Knowledge Base: https://www.advancedtherapiesconnect.ai/knowledge-base To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here: https://www.advancedtherapiesconnect.ai/ To learn more about Genoplex, please visit https://www.genoplex.ai

  Business
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


The Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024

Nov 11 2024 26 mins  
HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this podcast episode, Noe Gutierrez, the Head of Commercial Operations at Genoplex, Inc., shares many of the key themes and insights from the biggest health tech conference of 2024.

How NGGT is Pioneering the Next Wave of Gene Therapies

Oct 10 2024 40 mins  
Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder and Chief Operating Officer, Guang Qu, discusses how the company's dual-functional vector tech platform is being used to target many diseases.

Unlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker

Sep 18 2024 38 mins  
Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is Interleukin-2, or IL-2. Aulos Bioscience is an immuno-oncology company that has developed AU-007, a potential best-in-class IL-2, that improves on many of the other IL-2 products in development. In this episode, we discuss t

Left Behind: Addressing Health Equity for the Rare Disease Patient Community

Sep 09 2024 20 mins  
In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at Alexion, AstraZeneca Rare Disease. Tamar discussed her efforts to champion health policy, advocacy, equity, and awareness for rare diseases. Link to NMOSD video mentioned in episode: https://www.youtube.com/playlist?list

Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD

Sep 05 2024 30 mins  
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.

Unlocking AI In Oncology with James Zou, PhD

Aug 27 2024 24 mins  
In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford University, shares current use cases for AI in healthcare and oncology and discusses how we can overcome challenges with LLMs to unlock the full potential of AI.

Revolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan

Aug 21 2024 44 mins  
In this episode, Genoplex Founder and CEO, Chris Leidli, and CTO, Shoukri Kattan, take a dive deep into their shared passion for health, wellness, and longevity, and explore how technology is revolutionizing patient access to advanced therapies. Chris and Shoukri discuss the groundbreaking work happening at Genoplex, including how the company's Advanced Therapy Connect digital pl

Building a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine

Aug 14 2024 24 mins  
Our guest for this podcast episode is Robb Richards, Corporate Director of Cell Therapy and Transplant at University of Pennsylvania, Penn Medicine. In this episode, we discuss how Penn Medicine is working to improve patient access to cellular therapies and how technology has evolved to streamline operational and clinical workflows to enhance patient experience.

How MedStack helps Health Tech companies with Compliance and Data Privacy

Jul 28 2024 41 mins  
Our guest for this episode is Balaji Gopalan, CEO and Co-Founder of MedStack where we discuss how MedStack's tech stack is enabling digital health start-ups to be healthcare data compliant. MedStack streamlines compliance with out-of-the-box HIPAA controls and ready-to-use privacy policies, enabling the faster and more cost-effective development of digital health applications. Wi

How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System

Jul 08 2024 20 mins  
Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.